Another judge has railed against the use of generative AI in court proceedings, after a self-represented litigant filed an application to annul his bankruptcy that was replete with fake citations.
Martinus Rail has won its fight against grain supply chain Co-operative Bulk Handling over a $23 million payment claim for building a rail siding in WA, with a judge finding that the deadline for responding to the claim began running from a Saturday.
The developer of a 683-lot project in Glenmore Park, NSW has lost its bid to strike out parts of a class action by owners and investors alleging the land on which the development sits is unsuitable for residential construction.
NSW government-owned utility Hunter Water has been ordered to pay $1.2 million in damages to 118 owners in a townhouse block in Newcastle for flooding caused by a burst water main.
The developer of a tower in Mascot which is said to contain combustible cladding can opt out of a class action against 3A Composites and Halifax to bring its own claim for $15 million.
A judge has ordered tech company Vehicle Management Systems to hurry up and choose between damages or an account of profits in its IP dispute with the city of Melbourne over a sensor-based system for timing parked vehicles.
A judge has rejected all but two claims by ASIC in a suit against car finance provider Money3 and criticised how the regulator ran its case, saying it had consumed an “inordinate and disproportionate amount of the judicial and administrative resources of the court”.
Brittany Higgins must cover 80 per cent of Linda Reynolds’ legal costs on top of $315,000 in damages the former senator was awarded in her defamation case over social media posts that implied she mishandling Higgins’ rape allegations against Bruce Lehrmann.
A judge has signed off on a $13.5 million penalty agreed to by retailer The Good Guys for making misleading statements about store credit and StoreCash schemes to customers.
Regeneron and Bayer have lost their bid to block generic drug maker Sandoz from launching a biosimilar of their blockbuster eye drug Eylea.